Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cilag acquires JB Chemicals OTC brands
J&J signed a definitive agreement to acquire JB Chemicals in 26 May 2011, as part of its plan to widen its presence in Russia. The acquisition includes multi-symptom
J&J signed a definitive agreement to acquire JB Chemicals in 26 May 2011, as part of its plan to widen its presence in Russia. The acquisition includes multi-symptom
Firecrest, with its web-based solution, provides study information, training manuals for the study sites. ICON CEO Peter Gray said delivering consistent, real-time information to sites and a clear
The approval for Benlysta was granted as an additional therapy for the adult patients suffering from active autoantibody-positive systemic lupus erythematosus (SLE) with high degree of disease activity.
Brazil-based Engefiltro, which has filtration systems engineering capabilities, has presence across various industries including pharma. This expertise increases Pall’s regional capabilities in the design, construction and servicing of
Aptalis Pharma will offer Zenpep in 25,000 units of lipase for pateints with exocrine pancreatic insufficiency (EPI) caused by CF or other conditions. Aptalis Pharma president and CEO
The joint venture, which is a 50-50 partnership deal, is expected to provide active pharmaceutical ingredients (API) to various other pharmaceutical firms. With this manufacturing plant, the companies
The marketing authorization was granted on the basis of the results of three Phase 3 trials evaluating XGEVA versus zoledronic acid at delaying SREs. The results of the
The committee has also given 100% vote and recommended the FDA to also approve Adcetris as a treatment for patients with relapsed or refractory systemic anaplastic large cell
Life Technologies said the drug delivery technology is ready for license, as a part of a new out-licensing program. The product is expected to offer improvement and help
HealOr is a developer of new treatments for acute and chronic wounds such as diabetic foot ulcer (DFU), psoriasis and others. Most recently, Sabolinski has worked as the